Pharmafile Logo

Webinar: Understanding the Patient Journey in China 2015

January 6, 2016 | Chinese Healthcare, Patient journey 

Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and consider the possible implications for market researchers.

As the affluent middle-class continues to grow and healthcare reforms look set to affect the way that patients access treatment, the Chinese healthcare market is experiencing a period of great change. 

Most recently there are concerns that the devaluation in China’s currency has impacted significantly on the local healthcare demand and that the much publicised healthcare reforms that were due to take effect this year have stalled in the implementation. 

Now more than ever, the researcher needs to ensure that they have a full understanding of how these developments will impact the market.

Register now for the latest in our China webinar series where, utilising local knowledge and detailed case studies, we will examine the current Chinese healthcare market, discuss the likely impact of the Government’s healthcare reforms on the patient journey and consider the possible implication for market researchers.

Our Emerging Markets experts Marc Yates and Rachel Howard will also be considering the impact of China’s more recent financial challenges including the lack of growth within the private sector.

Gain answers to your key questions:

  • Gain a deeper understanding of the changing patient journey in China
  • Identify the opportunities and challenges associated with the healthcare reforms 
  • Learn how to ensure that your market research in China continues to answer the business objectives

To view the webinar please visit: bit.ly/1O05iUJ

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Eyeforpharma Real World Evidence Conference Round up 2018

Earlier this month, APAC Director Pei Li Teh attended Asia’s 11th Eyeforpharma conference in Tokyo, Japan with a focus on Real World Evidence (RWE)This year has seen a turning point...

EphMRA Annual Conference 2018

Visit us on stand number 20

Connected Patients – Adopting a patient-centric approach in emerging markets

The concept of patient centricity and putting the patient at the heart of care is being widely adopted by the healthcare industry – the general consensus being that it’s going...

Combination therapies in oncology: The benefits of integrated insights

14 June 2018 11am EDT | 8am PDT | 4pm BST | 5pm CE

Intellus round up 2018

Earlier this month, US President Harriet Kozak and Emerging Markets Director Rachel Howard attended the inaugural Intellus Worldwide Summit in Philadelphia

Janssen & Research Partnership win prestigious BHBIA Best Business Impact award

We are delighted to announce that Janssen and Research Partnership have won the BOBI (Best of Business Intelligence) Award in the Best Business Impact category at the BHBIA annual conference in London for our collaborative market research...

How published research underpinned a cancer therapy awareness campaign

Our client markets a product for Oral Mucositis (OM) - a side effect of cancer treatment - and wanted to better understand the disease and treatment challenges faced by both...

How integrated insights supported a biologic launch strategy across multiple indications

Our client is launching a new biologic in dermatology across indications and needed to understand the market, including the patient pool, treatment landscape, potential uptake and pricing opportunity for their...

How a hybrid approach delivered fast insights to feed into an oncology product’s adoption strategy

Our client wanted to quantify how ovarian cancer patients are managed prior to product launch, but also needed to understand why patients do or do not receive key diagnostic tests...